Table 1.
Ref. | Patients | Raised AST | Raised ALT | AST > ALT | Hyper-bilirubinemia | > 10 fold rise (AST, ALT) |
Kuo et al[37] | 270 | 93.30% | 82.20% | + | 7.20% | 11.1%, 7.4% |
Souza et al[39] | 1585 | 63.40% | 45% | + | - | 3.4%, 1.8% |
Itha et al[41] | 45 | 96% | 96% | Equal | 30% | - |
Wong et al[40] | 127 | 90.60% | 71.70% | + in 75.6% | 13.4% | 10.2%, 9.5% |
Parkash et al[33] | 699 | 95% | 86% | + | - | 15% |
Trung et al[36] | 644 | 97% | 97% | + | 1.7% | - |
Lee et al[14] | 690 | 86% | 46% | - | - | 1% |
Karoli et al[34] | 138 | 92% | + | 48% | - | |
Saha et al[35] | 1226 | 16.9% |
AST: Aspartate transaminase; ALT: Alanine transaminase.